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Abstract 
Background: To compare the efficacy of reduced 
osmolarity ORS with standard WHO ORS in 
children with acute diarrhoea. 
Methods:  In this comparative study  1080 children 
suffering from acute diarrhoea were selected from 
emergency. Children were divided randomly into 2 
groups. Group A was given reduced osmolarity ORS 
and Group B was given standard WHO ORS. 
Proforma was filled at the time of admission and 
after every four hours till there was no dehydration. 
Criteria of treatment efficacy was, need of 
unscheduled IV infusions, number of stools, 
improvement in number of episodes of vomiting and 
duration of hospital stay in hours.  
Results: A total of 1080 children with acute 
diarrhoea were included in the study.  540 children 
in group A were given reduced osmolarity ORS and 
540 children in group B were given WHO ORS. 
Efficacy of treatment was significantly good in group 
A (75%) as compared to group B (34%). Unscheduled 
IV infusion was less in group A as compared to  
group B. Number of stools were significantly 
reduced in group A as compared to group B. 
Vomiting during rehydration was also lesser in 
group A as compared to group B. Patients in group A 
had significantly reduced average duration of 
hospital stay as compared to group B. 
Conclusion:  Reduced osmolarity ORS reduced the 
duration and severity of symptoms in children with 
acute diarrhea and treatment was well tolerated with 
no side effects. 
Key Words:  Acute diarrhea, reduced osmolarity 
ORS. standard WHO ORS, unscheduled IV infusion.  
 
Introduction 
Diarrhoea emerges as major cause of mortality in 
children in developing countries. Diarrhoea is 
characterized by passing of three or more loose, 
watery stools per day.A large number of diarrheal 
deaths occur due to dehydration. Dehydration was 
treated with IV infusion initially. Dehydration must be 
evaluated rapidly and corrected in 4-6 hours according 
to degree of dehydration and estimated daily 
requirements. Oral rehydration therapy is the basis in 
the treatment of diarrheal episodes and in recent years, 
low osmolarity oral rehydration solution (ORS) has 
been recommended for rehydration. These electrolyte 
solutions can be used for rehydration as well as 
maintenance and can prevent most diarrhoea-related 
complications.  Laboratory work suggests that lower 
concentrations of sodium and glucose enhance solute 
induced water absorption. So, reduced osmolarity ORS 
might be advantageous for children with acute 
diarrhoea. 1 
Acute diarrhoea is defined as the passage of three or 
more stools per day with consistency softer than usual 
for a child or one watery stool per day1. Diarrhoea is a 
leading cause of childhood death in developing 
countries. It accounts for nearly 18% of childhood 
deaths, with almost 1.8 million deaths/year globally.2 
In 2008 diarrhea was estimated to have caused 1.1 
million deaths in children aged five and over and 1.5 
million deaths in children under the age of five in 
developing countries. Worldwide, children younger 
than 5 years have an estimated 1.7 billion episodes of 
diarrhoea each year, leading to 124 million clinic visits, 
9 million hospitalizations, and 1.34 million deaths, 
with more than 98% of these deaths occurring in the 
developing world.3,4,5,6 
 Lack of a system able to generate representative 
quality data regularly is one of the major obstacles for 
international and national planning to reduce under 5 
mortality7. Diarrheal illness may have a significant 
impact on the psychomotor and cognitive 
development in young children.8 WHO suspects that 
there are > 700 million episodes of diarrhoea/year in 
children < 5 years of age in developing countries.9 
Major risks are environmental contamination and 
increased exposure to enteropathogens.10 The main 
complication is dehydration, which until early 1960s 
was treated with IV infusion. Dehydration must be 
evaluated rapidly and corrected in 4-6 hours according 
to degree of dehydration and estimated daily 
requirements. 11,12 
Advent of oral rehydration salts (ORS) solution for the 
treatment of dehydration due to diarrhoea is 
considered to be one of the greatest achievements of 
medical research in the 20th century.13 Since it was 
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recommended by the World Health Organization 
(WHO) in 1978 for the management of all types of 
diarrhoea in all age-groups, numerous studies have 
been undertaken to develop an 'improved' ORS. The 
goal was to discover a product that would be at least 
as safe and effective as standard ORS solution for 
preventing or treating dehydration from all types of 
diarrhoea but which, in addition, would reduce stool 
output or have other important clinical benefits.  . Oral 
rehydration therapy is the mainstay in the treatment of 
diarrheal episodes, and in recent years, low osmolarity 
oral rehydration solution (ORS) has been 
recommended for rehydration.14 For more than two 
decades, WHO has recommended a standard 
formulation of glucose based ORS with 90 mmol/l of 
sodium and 111 mmol/l of glucose and a total 
osmolarity of 311 mmol/l. It remains unclear, 
however, if this is the optimum sodium concentration. 
Some studies have found patients with blood sodium 
concentrations above the normal level of 150 mmol/l.15 
Laboratory work suggests that lower concentrations of 
sodium and glucose enhance solute induced water 
absorption. 16 In one study it was observed that in first 
24 hrs, mean stool output (g/kg) was 114 vs. 125, 
vomiting occurs in 58% vs. 62%, duration of hospital 
stay was similar and proportion of children who 
required unscheduled IV therapy was 10% vs. 15% in 
children who received reduced osmolarity ORS as 
compared to those who received the WHO ORS 
respectively.17 
 
Patients and Methods 
This study was done in Department of Paediatrics , 
Holy Family Hospital Rawalpindi from 9th August 
2015 to 15th September 2015. Using WHO sample size 
criteria, the sample size was 1080. In randomized 
clinical trial there were 540 children in each group. 
Power of study was 80%. Significance level was taken 
as 10 %. p19 was 10 % and p29 was 15%  .  Children of 
either gender with acute diarrhoea having, age 3 
months to 2 years, diarrhoea of duration less than 5 
days and with some dehydration with consecutive 
non-probability sampling were studied and children 
having other systemic illnesses or cholera, children 
who are immunocompromised and third degree 
malnourished children (wt. <60% expected for that 
age) were excluded from the study.  Total 1080 
children suffering from acute diarrhoea were selected 
from emergency. Parents were informed about aims of 
study. Risks and benefits of reduced osmolarity and 
standard WHO ORS were explained to the parents. 
Informed written consent was taken from parents .The 
study protocol was reviewed and approved by the 
ethical committee. Children were divided randomly 
using random number table into 2 groups. Group A 
was  given reduced osmolarity ORS and group B were 
given standard WHO ORS under supervision of nurse 
incharge. Proforma was filled at the time of admission 
and after every four hours , till there was no 
dehydration. Criteria of treatment efficacy was taken 
as need of unscheduled IV infusions, improvement in 
number of episodes of vomiting, number of stools and 
duration of hospital stay in hours. Data analysis was 
done using Statistical Package for Social Sciences 
version 10. Quantitative variables i.e. age, number of 
stools, vomiting during rehydration and duration of 
hospital stay in hours were presented as mean and SD. 
Qualitative variables i.e. gender, need for unscheduled 
IV infusions and efficacy were presented as 
frequencies and percentages. Test of significance was 
applied. For qualitative data i.e. gender, need for 
unscheduled intravenous infusions and efficacy, Chi 
square test was used. For quantitative data i.e. age, no. 
of stools, vomiting during rehydration and duration of 
hospital stay in hours, t-test was applied and  p value 
less than .05 was taken as statistically significant. 
 
Results 
 A total of 1080 children with acute diarrhea were 
included in the study. We analyzed the record of 540 
children in group A (Reduced osmolarity ORS given) 
and 540 children in group B (WHO ORS given). The 
clinical parameters of both groups at the time of 
admission including age, weight, duration of illness, 
signs and symptoms and their distribution were not 
statistically different. Mean age was 14.51±6.90 
months, ranging from 3 months to 24 months. Of these 
620(57.4%) were from 3-13 months(316 in group A and 
304 in group B) and 460 (42.6%) were from 14-24 
months( 224 in group A and 236 in group B). Of the 
total patients, 595 were males (55.1%) and 485 were 
females (44.9%).(Table 1 &2). Efficacy was significantly 
improved in group A (75%) as compared to group B 
(34%), having Chi square value of 182.394 , df value 1 
and one sided p value <0.00005.(Table 3) Unscheduled 
IV infusion was given in 45.5% patients . In group A, 
only 25 %( 135) patients needed IV infusion as 
compared to group B in which 65.95% (356) were 
given IV infusion (Chi square 182.394, df 1 and one 
sided p value of<0.00005).(Table 4)  Average numbers 
of stools was 4 ±2.17 in group A as compared to 
5.35±2.58 in group B. (t- test -0.458, df 1047.6 and one 
sided p value =0.00005). Average episodes of vomiting 
were 0.57±0.78 in group A as compared to 1.21±1.05 in 
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group B (t test -11.505, df 997.454 and one sided p 
value =0.00005). Average duration of hospital stay was 
also significantly reduced in patients of group A 
7.79±4.41 as compared to group B 10.78±5.18 (t test -
10.197, df 1050.97 and one sided p value 
=0.00005)(Table 5&6) 
Table 1 .Distribution of cases by age 
Age(Months) Number Percentage% 
3-13 620 57.4 
14-24 460 42.6 
Total 1080 100 
Mean SD 14.51±6.90 
Table 2.Distribution of cases by gender 
Gender Number Percentage% 
Male 595 55.1 
Female 485 44.9 
Total 1080 100 
Table 3.Efficacy of treatment 
Treatment Present Not Present 
Reduced osmolarity ORS 405(75%) 135(25%) 
WHO ORS 184(34%) 356(65.9%) 
 589(54.5%) 491(45.5%) 
Chi sq 182.394, df 1, one  sided p <0.00005 
Table 4. Frequency of unscheduled IV infusion 
 
Group 
Given Not Given 
A 135(25%) 405(75%) 
B 356(65.9%) 184(34.1%) 
 491(45.5%) 589(54.5%) 
Table 5. Secondary outcome measures 
Group Number 
Of Stools 
Vomiting Duration Of 
Hospital Stay 
A 4±2.17 0.57±0.78 7.79±4.41 
B 5.35±2.58 1.21±1.05 10.78±5.18 
Table  6. t- test 
Study Variables t value df 
One 
sided 

















1050.9 0.00005 -2.99 0.29 
Discussion 
In the present study, we wanted to find out whether a 
reduction in osmolarity would improve the 
rehydrating properties of the oral rehydration 
solution. For more than 25 years WHO & UNICEF 
have recommended single formulation of glucose 
based ORS to prevent or treat dehydration from 
diarrhea irrespective of cause or age group affected. 
This product has proven effective & contributed 
substantially to the dramatic global reduction in 
mortality from diarrhea during the period.  Based on 
more than two decades of research & 
recommendations by an expert group, WHO & 
UNICEF received the effectiveness of a new ORS 
formula with reduced concentration of glucose & salts. 
Reduced osmolarity rehydration solution was 
associated with reduced need for unscheduled 
intravenous infusions, lower stool volume and less 
vomiting compared with standard WHO rehydration 
solution. 18 Because of the improved effectiveness of 
this new ORS solution, WHO & UNICEF 
recommended that countries use and manufacture this 
new formulation in place of old one. 
Therapy of acute watery diarrhoea requires 
replenishing water and electrolyte losses (rehydration 
phase) and maintaining water and electrolyte balance 
after rehydration until diarrhoea ceases (maintenance 
phase). Oral rehydration is successful when 
hourly oral intake matches or modestly exceeds fluid 
losses (regardless of gross stool rate). When the 
solution contains appropriate amounts of sodium, 
potassium, and bicarbonate or base-
precursor, electrolyte balance is also restored and 
maintained. Dehydrated patients in shock need rapid 
intravenous rehydration followed by oral 
maintenance. If intravenous fluids or skilled 
personnel are unavailable, oral rehydration and 
maintenance can be effective even in hypotensive 
patients. With lesser degrees of dehydration, most 
patients respond without intravenous fluids, and 
dehydration can be prevented by early oral 
maintenance therapy. For years, the WHO has 
encouraged the use of a single ORS formulation to be 
used for all ages and all causes of infectious diarrhea 
and the effectiveness of this approach has been 
enormous. Laboratory work suggests that lower 
concentrations of sodium and glucose enhance solute 
induced water absorption and improves symptoms 
earlier. Patients with acute diarrhoea might be 
benefited by use of reduced osmolarity oral 
rehydration solution. 
 In our study, we compared treatment efficacy of 
reduced osmolarity oral rehydration solution with 
standard WHO oral rehydration solution in patients 
with acute diarrhoea. There was significant 
improvement in all the parameters compared. Patient 
given reduced osmolarity ORS had shown 
significantly improved treatment efficacy that was 
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measured in terms of significantly reduced need for 
unscheduled IV rehydration solution, lesser numbers 
of stool, lesser episodes of vomiting and shorter 
duration of hospital stay. There was no significant 
adverse effect during treatment. There are lot of 
studies that had been done to measure effectiveness of 
reduced osmolarity ORS and shown to had good 
results. Reduced osmolarity ORS is now being 
recommended as first line treatment in patients of 
acute diarrhoea worldwide. But in our country still 
WHO ORS is being used for oral rehydration. Policy 
makers must take some measures for recommendation 
of reduced osmolarity oral rehydration solution by its 
easy availability and awareness of general population 
regarding its effectiveness.   14-18          
 
Conclusion 
1.Use of reduced osmolarity ORS in acute diarrhoea in 
children improves symptoms earlier and reducing 
need of unscheduled IV infusion and duration of 
hospital stay.  
2. It is likely to reduce the disease burden and financial 
burden on parents and hospital. It  can also help  in 
removing the problem like cross infection with other 
microorganisms during prolonged hospital stay, drug 
resistance and opportunistic infections.  
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